Cargando…
Trial designs using real‐world data: The changing landscape of the regulatory approval process
PURPOSE: There is a need to develop hybrid trial methodology combining the best parts of traditional randomized controlled trials (RCTs) and observational study designs to produce real‐world evidence (RWE) that provides adequate scientific evidence for regulatory decision‐making. METHODS: This revie...
Autores principales: | Baumfeld Andre, Elodie, Reynolds, Robert, Caubel, Patrick, Azoulay, Laurent, Dreyer, Nancy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687110/ https://www.ncbi.nlm.nih.gov/pubmed/31823482 http://dx.doi.org/10.1002/pds.4932 |
Ejemplares similares
-
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
por: Yap, Timothy A., et al.
Publicado: (2022) -
The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making
por: Baumfeld Andre, Elodie, et al.
Publicado: (2022) -
Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
por: Maeda, Hideki, et al.
Publicado: (2022) -
Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018) -
Modernizing Regulatory Evidence with Trials and Real-World Studies
por: Dreyer, Nancy A., et al.
Publicado: (2020)